Arcellx (ACLX) Non-Current Assets (2021 - 2025)

Arcellx's quarterly Non-Current Assets came in at $141.8 million in Q4 2025, up 26.59% year-on-year from $112.0 million in Q4 2024, and down 22.86% quarter-over-quarter from $183.8 million in Q3 2025.

Arcellx has reported Non-Current Assets for 5 years, with the latest figure at $141.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 26.59% year-over-year to $141.8 million; the trailing twelve-month figure through Dec 2025 stood at $574.8 million (down 16.06% YoY), and the FY2025 full-year result was $141.8 million, up 26.59% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $141.8 million, down from $183.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $204.1 million in Q2 2024, with the low at $16.0 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $105.3 million, with a median of $108.8 million recorded in 2023.
  • Year-over-year, Non-Current Assets surged 270.25% in 2024 and tumbled 50.81% in 2025.
  • Tracing ACLX's Non-Current Assets over 5 years: stood at $16.0 million in 2021, then jumped by 193.96% to $47.0 million in 2022, then surged by 131.65% to $108.8 million in 2023, then gained by 2.99% to $112.0 million in 2024, then climbed by 26.59% to $141.8 million in 2025.
  • The last three Non-Current Assets figures came in at $141.8 million (Q4 2025), $183.8 million (Q3 2025), and $155.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 141.81 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 141.81 Mn
Sep 30, 2025 183.84 Mn
Jun 30, 2025 155.19 Mn
Mar 31, 2025 93.93 Mn
Dec 31, 2024 112.02 Mn
Sep 30, 2024 177.61 Mn
Jun 30, 2024 204.10 Mn
Mar 31, 2024 190.96 Mn
Dec 31, 2023 108.77 Mn
Sep 30, 2023 122.76 Mn
Jun 30, 2023 65.46 Mn
Mar 31, 2023 51.58 Mn
Dec 31, 2022 46.95 Mn
Sep 30, 2022 47.02 Mn
Jun 30, 2022 49.58 Mn
Mar 31, 2022 22.60 Mn
Dec 31, 2021 15.97 Mn